Detalles de la búsqueda
1.
Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.
Breast Cancer Res
; 23(1): 87, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425869
2.
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.
BMC Cancer
; 17(1): 137, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28202004
3.
Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors.
Oncology
; 91(5): 251-260, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27598338
4.
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancer.
Invest New Drugs
; 31(1): 136-44, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22492020
5.
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2--Advanced Breast Cancer.
Clin Cancer Res
; 27(21): 5801-5809, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376533
6.
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial.
JAMA Oncol
; 6(1): 116-124, 2020 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563959
7.
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.
Front Oncol
; 10: 578756, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33194700
8.
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer.
Lung Cancer
; 108: 212-216, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28625637
9.
Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non-Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy.
Clin Lung Cancer
; 17(1): 80-4, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26432508
10.
Withholding/withdrawal of life support in trauma patients: is there an age bias?
Am Surg
; 68(2): 159-62, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11842963
11.
A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.
Eur Urol
; 65(3): 516-20, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246407
Resultados
1 -
11
de 11
1
Próxima >
>>